Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Endobronchial Ultrasound Biopsy Market Size Forecast: How Large Could The Market Become By 2030?

The endobronchial ultrasound biopsy market has shown strong growth over recent years. It is projected to increase from $0.66 billion in 2025 to $0.71 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. The expansion witnessed in the historic period is attributable to the increasing occurrence of lung cancer cases, the wider acceptance of minimally invasive diagnostic procedures, an increase in hospital-based bronchoscopy units, continuous advancements in ultrasound-guided biopsy technologies, and a greater understanding of the importance of early diagnosis for thoracic diseases.

The endobronchial ultrasound biopsy market size is projected to experience robust expansion over the coming years, reaching $0.93 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is primarily driven by factors such as a surge in demand for precision-guided pulmonary diagnostics, the increasing acceptance of single-use biopsy devices, the broadening of AI-enabled bronchoscopy imaging systems, escalating investments in cancer diagnostic infrastructure, and a greater use of outpatient and ambulatory biopsy procedures. Key trends anticipated during this period encompass a rise in the adoption of minimally invasive mediastinal biopsy procedures, a growing inclination towards single-use endobronchial ultrasound devices, an increasing need for real-time lymph node sampling accuracy, the expansion of lung cancer screening and diagnostic programs, and an elevated application of advanced ultrasound-guided peripheral lung lesion localization.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample_request?id=76897547&type=smp

Endobronchial Ultrasound Biopsy Market Industry Drivers: What Is Driving Revenue Growth?

The rising occurrence of lung cancer is anticipated to stimulate the advancement of the endobronchial ultrasound biopsy market moving forward. Lung cancer is characterized as a malignant tumor involving uncontrolled cellular proliferation in lung tissues, which can spread to nearby areas or metastasize to distant organs. The prevalence of lung cancer is increasing due to elements such as heightened smoking rates and environmental exposures that raise the risk of lung malignancy. Endobronchial ultrasound biopsy offers precise, minimally invasive sampling of lung and mediastinal tissues, enabling accurate diagnosis, staging, and monitoring of lung cancer, which in turn informs specific treatment strategies and improves patient outcomes. For instance, in March 2026, Cancer Research UK (CRUK) indicated that for women in the UK, the European age-standardised (AS) incidence rate of lung cancer is projected to increase by 2% between 2024–2026 and 2038–2040, climbing from approximately 75.8 to 77.6 cases per 100,000 women per year. Thus, the escalating incidence of lung cancer is propelling the expansion of the endobronchial ultrasound biopsy market.

Endobronchial Ultrasound Biopsy Market Segmentation And Category Breakdown

The endobronchial ultrasound biopsy market covered in this report is segmented –

1) By Procedure Type: Convex Probe Endobronchial Ultrasound Guided Biopsy, Radial Probe Endobronchial Ultrasound Guided Biopsy

2) By Product Type: Endobronchial Ultrasound Scopes, Biopsy Needles And Sampling Consumables, Ultrasound Processors And Imaging Systems, Accessories And Ancillary Devices

3) By Usability: Reusable Devices, Single Use Devices

4) By Application: Lung Cancer Diagnosis And Staging, Granulomatous And Infectious Disease Evaluation, Other Applications

5) By End User: Hospitals And Specialty Cancer Centers, Ambulatory Surgical Centers, Diagnostic Imaging And Biopsy Centers

Subsegments:

1) By Convex Probe Endobronchial Ultrasound Guided Biopsy: Transbronchial Needle Aspiration Guided Procedures, Real Time Lymph Node Sampling Procedures, Mediastinal Staging Biopsy Procedures, Central Lung Lesion Biopsy Procedures, Combined Bronchoscopic Ultrasound Guided Sampling Procedures

2) By Radial Probe Endobronchial Ultrasound Guided Biopsy: Peripheral Lung Lesion Localization Procedures, Guide Sheath Assisted Biopsy Procedures, Transbronchial Forceps Biopsy Procedures, Brush Cytology Sampling Procedures, Fluoroscopy Assisted Peripheral Biopsy Procedures

#Endobronchial Ultrasound Biopsy Market Growth Trends: What Is Influencing The Future Outlook?

Leading companies in the endobronchial ultrasound biopsy market are concentrating on developing innovative products, such as next-generation EBUS bronchoscopes, to enhance diagnostic accuracy and improve minimally invasive lung cancer procedures. These advanced endoscopic devices, known as next-generation EBUS bronchoscopes, integrate high-resolution ultrasound probes, allowing for real-time imaging of airways and lymph nodes. This capability assists clinicians in performing more precise, minimally invasive lung biopsies compared to traditional bronchoscopes. As an illustration, in September 2025, Olympus Corporation, a Japan-based medical technology company, introduced the BF-UC190F EBUS bronchoscope, a groundbreaking device engineered to boost diagnostic accuracy and procedural efficiency in thoracic oncology. The BF-UC190F incorporates a thinner, more flexible insertion tube, a high-resolution ultrasound probe, and improved maneuverability, thereby enabling clinicians to access hard-to-reach lymph nodes while simultaneously reducing patient discomfort. Its ergonomic design and enhanced imaging capabilities support safer, faster biopsies and decrease the requirement for repeat procedures. This sophisticated bronchoscope is particularly valuable in the early detection and staging of lung cancer, providing real-time guidance for needle aspiration and tissue sampling.

Endobronchial Ultrasound Biopsy Market Competitive Analysis Of Major Industry Participants

Major companies operating in the endobronchial ultrasound biopsy market are Medtronic plc, Siemens Healthcare Private Limited, FUJIFILM Holdings Corporation, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Boston Scientific Corporation, Konica Minolta Inc., Intuitive Surgical Inc., Olympus Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., STERIS plc, Teleflex Incorporated, Canon Medical Systems Corporation, Cook Group Incorporated, CONMED Corporation, PENTAX Medical, Esaote S. p. A., Medi-Globe Technologies GmbH, ENDO-FLEX GmbH, Taewoong Medical Co. Ltd., ACE Medical Devices Private Limited, Body Vision Medical Ltd., Clinodevice S. r. l.

Access The Complete Endobronchial Ultrasound Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/endobronchial-ultrasound-biopsy-market-report

Endobronchial Ultrasound Biopsy Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the endobronchial ultrasound biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endobronchial ultrasound biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model